Tech Company Financing Transactions
Serif Biomedicines Funding Round
On 4/21/2026, Serif Biomedicines raised $50 million in investment from private investors.
Transaction Overview
Company Name
Announced On
4/21/2026
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
124 First Street 402
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Undisclosed
Website
Email Address
Overview
Our team combines deep expertise in nucleic acid discovery, development, and delivery with a track record of creating category-defining technologies. We are scientists, engineers, and company builders united by a mission: to build a future where DNA becomes the source code for medicines that can be tailored across diseases and scaled for global impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Rubens
Chief Financial Officer
Andy Oh
Chief Scientific Officer
Pete Smith
Vice President
Shinu John
Vice President
Matt Kennedy
Browse more venture capital transactions:
Prev: 4/21/2026: Geopyörä venture capital transaction
Next: 4/21/2026: Humble Robotics venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs